Britain’s medicines regulator said on Thursday it had approved AstraZeneca’s antibody-based treatment to prevent COVID-19 in people whose immune response is poor. – Reuters
Read Today's News TODAY... on our Telegram Channel click here to join and receive all the latest updates t.me/thetimeskuwait
